how do you stop semaglutide Vitality Health What really happens to your

With both oral and injectable branded medications available, your choice depends on personal comfort, preferences, and insurance

Dev Med Child Neurol 1991;33:795-802

After 6 months of therapy, those taking GLP1 drugs showed: Elevated risk of androgenic alopecia Elevated risk of nonscarring hair loss No significant change in telogen effluvium risk No significant change in alopecia areata risk At the 12-month mark, the pattern had shifted slightly: Continued higher risk for androgenic alopecia Continued higher risk for nonscarring hair loss A newly increased risk of telogen effluvium Still no change in risk of alopecia areata The apparent absence of a link between GLP1 medications and alopecia areata is especially notable, as isolated case reports have previously suggested an association

Stene, C

The latter may help to lower blood pressure and, as a result, reduce the workload on the heart